News | March 31, 2026
Samsung Biologics scores big at 2026 CDMO Leadership Awards
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
The move comes as drug developers face mounting pressure from faster timelines and increasingly complex manufacturing processes
It promises fewer injections for vision loss patients
This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
Zydus has developed an innovative formulation of Semaglutide Injection in a prefilled cartridge administered using a reusable patient-friendly pen device
The initial consideration for the transaction is US$ 12 million
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
Subscribe To Our Newsletter & Stay Updated
